All In Biotech

Drug Trial Radar · NCT00456521

A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of Naltrexone Sustained Release (SR)/Bupropion SR and Placebo in Subjects With Obesity Participating in a Behavior Modification Program

Last checked: Nov 19, 2026Latest source record: Dec 17, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 793 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

793

Actual

Start

Mar 2007

Primary completion

Dec 2008

Study completion Dec 2008

Sponsor

Lead sponsor
Orexigen Therapeutics, IncIndustry
Sponsor type
Industry
First posted
Apr 5, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether a combination of naltrexone SR and bupropion SR is safe and effective in treating obesity and leads to greater weight loss when given with a group lifestyle modification program than with group lifestyle modification alone.

Conditions

  • Obesity
  • Overweight

Interventions

  • Naltrexone SR 32 mg/ bupropion SR 360 mg/ dayDrug

  • PlaceboDrug

  • Intensive group lifestyle modification counselingBehavioral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Co-primary: Body Weight- Mean Percent ChangeTime frame: Baseline, 56 weeks
  2. Co-primary: Body Weight- Proportion of Subjects With ≥5% DecreaseTime frame: Baseline, 56 weeks

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • University of California, San Diego: Dept of Family & Preventive Medicine

    La Jolla, California

  • Center for Human Nutrition, University of Colorado Health Services Center

    Denver, Colorado

  • Univ. of Florida, College of Public Health, and Health Professions

    Gainesville, Florida

  • Washington Univ. Center for Human Nutrition

    St Louis, Missouri

  • New York Obesity Research Center, St. Luke's-Roosevelt Hospital Center

    New York, New York

  • Center for Weight and Eating Disorders, School of Med., University of Penn.

    Philadelphia, Pennsylvania

  • Center for Obesity Research and Education, Temple University

    Philadelphia, Pennsylvania

  • Medical University of S. Carolina Weight Management Center

    Charleston, South Carolina

  • Behavioral Medicine Research Center

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.